Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.
Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.